Evidence map›Paper›PMID 41924921›Full record

ArticleHaematologica2026

Azacitidine-induced remission enables allogeneic transplantation in

Carmen de Ramon Ortiz, Hana Abouzeid, Chiara De Bernardi, André Durham, Gregory Mathoux, Stavroula Masouridi, Thomas A Mckee, David Sibon, Olivier Hermine, David M Weinstock and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carmen de Ramon OrtizOncology Department, Geneva University Hospitals, 1205 Geneva.
Hana AbouzeidDepartment of Clinical Neurosciences, Geneva University Hospitals, 1205 Geneva.
Chiara De BernardiOncology Department, Geneva University Hospitals, 1205 Geneva.
André DurhamOncology Department, Geneva University Hospitals, 1205 Geneva.
Gregory MathouxDivision of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, 1205 Geneva.
Stavroula MasouridiOncology Department, Geneva University Hospitals, 1205 Geneva.
Thomas A MckeeDivision of Clinical Pathology, Geneva University Hospital, 1205 Geneva.
David SibonLymphoid Hematology Department, Henri Mondor University Hospital, AP-HP, and Paris-Est Créteil University, Créteil.
Olivier HermineDepartment Hematology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Imagine Institute, INSERM U1123, Paris.
David M WeinstockMedical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA.
Kristof EgervariDivision of Clinical Pathology, Geneva University Hospital, 1205 Geneva.
Jerome TamburiniOncology Department, Geneva University Hospitals, 1205 Geneva, Switzerland; Centre for Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Centre Leman, 1206 Geneva. jerome.tamburinibonnefoy@unige.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41924921
PMCPMC13628064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.